Berwyn's QR Pharma develops novel treatments for brain disorders
QR Pharma of Berwyn is a specialty pharmaceutical company developing novel treatments for Alzheimer's, Parkinson's and other neurodegenerative disorders.
QR Pharma of Berwyn is a specialty pharmaceutical company developing novel treatments for Alzheimer's, Parkinson's and other neurodegenerative disorders.
Coal tech firm leads way among Erie area contenders.
Ben Franklin Technology Partners of Central & Northern PA, also marking the big 3-0, announced $1.2 million in funding for eight startups.
BFTP-SEP marks its 30th anniversary with $1.9 million in funding to 10 young companies.
Universities across Pennsylvania are the beneficiaries of a new grant program by The Charles E. Kaufman Foundation to fund scientific research.
The Pittsburgh Life Sciences Greenhouse has embraced a new focus on later-stage companies and healthcare information technology.
Drexel's LeBow College of Business is launching an innovative student investment program alongside the Dragon Fund, now one of the largest student-managed investment portfolios in the country.
The nearly 10 year-old medical research company is offering a finder's fee for a programmer/developer as the global aptamers market targets the $2B mark by 2018.
KannaLife Sciences, a Doylestown company, is at the vanguard of research and development of pharmaceutical products derived from plants � specifically cannabis.
This innovative arm of the Science Center argues that creativity is essential to scientific discovery, while also giving artists and students access to the latest high-tech tools.